{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-020750","form_type":"8-K","ticker":"VVOS","cik":"0001716166","company_name":"Vivos Therapeutics, Inc.","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.241610+00:00","generated_at":"2026-05-17T00:39:35.250893+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Vivos Therapeutics 2025 annual meeting elects directors, approves equity plan amendment, ratifies auditor","bullets":["All six director nominees elected: Huntsman, Green, Krammer, Lindsay, Sokolow, Thompson; each with >2.6M votes for.","Amendment to 2024 Omnibus Equity Incentive Plan approved with 2.45M for, 516K against, 2.3K abstain.","Appointment of Baker Tilly US, LLP as auditor for FY ending Dec 31, 2025 ratified with 4.86M for."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-020750","json":"https://secwatch.observer/filing/0001493152-25-020750.json","markdown":"https://secwatch.observer/filing/0001493152-25-020750.md","text":"https://secwatch.observer/filing/0001493152-25-020750.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716166/000149315225020750/0001493152-25-020750-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716166/000149315225020750/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:39:35.250893+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}